• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INVIVE; IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INVIVE; IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT) Back to Search Results
Model Number W173
Device Problems Premature Discharge of Battery (1057); Pacing Problem (1439); Interrogation Problem (4017)
Patient Problem Bradycardia (1751)
Event Date 12/22/2022
Event Type  Injury  
Event Description
It was reported that during routine follow-up, this cardiac resynchronization therapy pacemaker (crt-p) was unable to be interrogated.Pacing inhibition was also reported.Subsequently, the patient underwent a revision procedure, and this device was explanted and replaced without incident.Besides intervention, there were no other adverse patient effects reported.Device return is expected.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, analysis confirmed the clinical observation of no telemetry or pacing output.The device case was opened, and visual inspection revealed no irregularities.Testing found that the battery had depleted earlier than expected.When connected to an external power source, the device passed all tests and operated normally.No high current drain or other device anomaly was identified during analysis.Although the clinical observations were caused by a depleted battery, laboratory analysis was unable to reproduce the condition that caused the battery to deplete prematurely.
 
Event Description
It was reported that during routine follow-up, this cardiac resynchronization therapy pacemaker (crt-p) was unable to be interrogated.Pacing inhibition and suspected early battery depletion was also reported.Subsequently, the patient underwent a revision procedure, and this device was explanted and replaced without incident.Besides intervention, there were no other adverse patient effects reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INVIVE
Type of Device
IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key16070985
MDR Text Key306362276
Report Number2124215-2022-55473
Device Sequence Number1
Product Code LWP
Combination Product (y/n)N
Reporter Country CodeSP
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/29/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date07/20/2015
Device Model NumberW173
Device Catalogue NumberW173
Device Lot Number116053
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/15/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/26/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-